Here's the live share price of AstraZeneca Pharma India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of AstraZeneca Pharma India has gained 16.12% CAGR. Over the past year, the corresponding return has been 32.82%.
AstraZeneca Pharma India’s current P/E of 123.80x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
AstraZeneca Pharma India | -0.14 | 4.81 | -10.84 | 17.51 | 32.74 | 39.66 | 16.01 |
Sun Pharmaceutical Industries | 0.70 | -0.99 | -4.81 | -4.20 | -13.89 | 21.90 | 26.52 |
Divi's Laboratories | 0.67 | 1.49 | -10.01 | 6.79 | 10.37 | 18.09 | 13.84 |
Cipla | 1.13 | 3.30 | 4.58 | 8.05 | -5.20 | 13.90 | 16.86 |
Torrent Pharmaceuticals | 0.39 | -0.95 | 10.23 | 16.07 | 3.87 | 33.59 | 20.78 |
Dr. Reddy's Laboratories | 3.02 | 7.07 | -4.13 | 18.24 | -2.24 | 15.37 | 8.44 |
Mankind Pharma | 2.02 | 7.08 | 9.06 | 19.99 | 7.03 | 22.46 | 12.92 |
Zydus Lifesciences | 3.34 | 9.62 | 7.10 | 17.89 | -6.44 | 40.68 | 23.26 |
Lupin | 4.56 | 4.60 | 0.55 | 3.47 | -9.50 | 44.71 | 16.02 |
Abbott India | -0.28 | -3.87 | -1.22 | 4.25 | 4.65 | 19.70 | 13.47 |
Alkem Laboratories | 1.94 | 5.62 | 12.29 | 14.52 | -14.28 | 19.30 | 13.33 |
Aurobindo Pharma | 6.38 | 5.01 | -3.81 | 0.37 | -28.79 | 26.41 | 6.95 |
Glenmark Pharmaceuticals | 3.75 | 3.57 | 30.08 | 49.93 | 21.89 | 76.21 | 34.63 |
Biocon | 0.56 | 3.09 | 3.82 | 12.57 | -2.84 | 6.45 | -3.18 |
Laurus Labs | 2.68 | 8.88 | 35.78 | 54.84 | 78.45 | 18.35 | 27.74 |
GlaxoSmithKline Pharmaceuticals | 1.97 | 9.11 | -14.88 | 5.32 | -1.29 | 25.82 | 10.38 |
Anthem Biosciences | -1.14 | 10.33 | 12.31 | 12.31 | 12.31 | 3.95 | 2.35 |
Cohance Lifesciences | 7.10 | 4.07 | -1.70 | -14.61 | -16.74 | 27.54 | 22.21 |
Ipca Laboratories | -1.18 | -4.13 | -4.61 | 0.20 | -9.38 | 14.74 | 4.23 |
Gland Pharma | 3.98 | 2.20 | 18.14 | 24.79 | 4.21 | -5.98 | 1.54 |
Over the last one year, AstraZeneca Pharma India has gained 32.74% compared to peers like Sun Pharmaceutical Industries (-13.89%), Divi's Laboratories (10.37%), Cipla (-5.20%). From a 5 year perspective, AstraZeneca Pharma India has outperformed peers relative to Sun Pharmaceutical Industries (26.52%) and Divi's Laboratories (13.84%).
Day | SMA | EMA |
---|---|---|
5 | 9,060.4 | 9,028.27 |
10 | 8,886.81 | 8,932.96 |
20 | 8,635.64 | 8,831.83 |
50 | 8,878.2 | 8,821.41 |
100 | 8,835.21 | 8,676.09 |
200 | 8,044.24 | 8,196.99 |
In the latest quarter, AstraZeneca Pharma India remained same as its previous close in promoter holding, while DII stake decreased to 4.55%, FII holding rose to 3.03%, and public shareholding moved down to 17.41% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Nippon India Small Cap Fund | 6,58,075 | 0.92 | 604.51 |
Nippon India Pharma Fund | 62,568 | 0.66 | 57.48 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 55,021 | 0.83 | 50.54 |
Samco Flexi Cap Fund | 26,087 | 5.79 | 23.96 |
Bandhan Hybrid Equity Fund | 16,167 | 1.37 | 14.85 |
ICICI Prudential ESG Exclusionary Strategy Fund | 8,213 | 0.5 | 7.54 |
ICICI Prudential Retirement Fund - Pure Equity | 8,122 | 0.56 | 7.46 |
Nippon India Nifty Smallcap 250 Index Fund | 7,821 | 0.29 | 7.18 |
Bandhan Large Cap Fund | 5,737 | 0.27 | 5.27 |
ICICI Prudential Manufacturing Fund | 5,094 | 0.07 | 4.68 |
Date Time | Announcement |
---|---|
Sep 11, 2025, 12:52 AM IST | AstraZeneca Pharma I - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Sep 02, 2025, 11:01 PM IST | AstraZeneca Pharma I - Disclosure under Regulation 30A of LODR |
Sep 02, 2025, 1:32 AM IST | AstraZeneca Pharma I - Disclosure under Regulation 30A of LODR |
Aug 19, 2025, 2:14 AM IST | AstraZeneca Pharma I - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Aug 14, 2025, 11:44 PM IST | AstraZeneca Pharma I - Shareholder Meeting / Postal Ballot-Outcome of AGM |
AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1716.29 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for AstraZeneca Pharma India is ₹9,080.35 as on Sep 12, 2025.
The AstraZeneca Pharma India is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of AstraZeneca Pharma India is ₹22,700.88 Cr as on Sep 12, 2025.
Today’s highest and lowest price of AstraZeneca Pharma India are ₹9,090.00 and ₹9,025.75.
The 52-week high/low is the highest and lowest price at which AstraZeneca Pharma India stock has traded in the past 52-week or nearly a year. The 52-week high of AstraZeneca Pharma India is ₹10,653.05 and 52-week low of AstraZeneca Pharma India is ₹6,222.35 as on Sep 12, 2025.
The AstraZeneca Pharma India has shown returns of 0.16% over the past day, 4.87% for the past month, -10.79% over 3 months, 32.82% over 1 year, 39.88% across 3 years, and 16.12% over 5 years.
P/E ratio of and PB ratio of AstraZeneca Pharma India are 123.80 and 33.42 on Sep 12, 2025. While the company gives a dividend yield of 0.35 per annum.